Comparison of acute and chronic antioxidant interventions in experimental renovascular disease

American Journal of Physiology - Renal Physiology

Volumn 286, Issue 6 55-6, 2004, Pages

  Chade, Alejandro R ^a   Krier, James D ^a   Rodriguez Porcel, Martin ^a   Breen, Jerome F ^a   McKusick, Michael A ^a   Lerman, Amir ^a   Lerman, Lilach O ^a  

^a MAYO CLINIC   (United States)

Author keywords

Antioxidants; Oxidative stress; Renal function; Tempol

Indexed keywords

3 NITROTYROSINE; ACETYLCHOLINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SUPEROXIDE DISMUTASE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTRON BEAM TOMOGRAPHY; ENDOTHELIUM CELL; EX VIVO STUDY; GLOMERULUS FILTRATION RATE; HYPERCHOLESTEROLEMIA; HYPOTHESIS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY ARTERY STENOSIS; KIDNEY BLOOD FLOW; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY PARENCHYMA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RENOVASCULAR DISEASE; SWINE; TISSUE INJURY;

EID: 2442715127     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00385.2003     Document Type: Article

References (55)

1. Asmis R and Begley JG. Oxidized LDL promotes peroxide-mediated mitochondrial dysfunction and cell death in human macrophages: a caspase-3-independent pathway. Circ Res 92: E20-E29, 2003.
2. Bjorneboe A, Bjorneboe GE, and Drevon CA. Serum half-life, distribution, hepatic uptake and biliary excretion of alpha-tocopherol in rats. Biochim Biophys Acta 921: 175-181, 1987.
3. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, and Green MS. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356: 1213-1218, 2000.
4. Carr AC, McCall MR, and Frei B. Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. Arterioscler Thromb Vasc Biol 20: 1716-1723, 2000.
5. Chade AR, Best PJ, Rodriguez-Porcel M, Herrmann J, Zhu X, Sawamura T, Napoli C, Lerman A, and Lerman LO. Endothelin-1 receptor blockade prevents renal injury in experimental hypercholesterolemia. Kidney Int 64: 962-969, 2003.
6. Chade AR, Rodriguez-Porcel M, Grande JP, Krier JD, Lerman A, Romero JC, Napoli C, and Lerman LO. Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 106: 1165-1171, 2002.
7. Chade AR, Rodriguez-Porcel M, Grande JP, Zhu X, Sica V, Napoli C, Sawamura T, Textor SC, Lerman A, and Lerman LO. Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol 23: 1295-1301, 2003.
8. Chade AR, Rodriguez-Porcel M, Herrmann J, Krier JD, Zhu X, Lerman A, and Lerman LO. Beneficial effects of antioxidant vitamins on the stenotic kidney. Hypertension 42: 605-612, 2003.
9. 1 receptor blockade improves renal perfusion in hypercholesterolemia. Am J Hypertens 16: 111-115, 2003.
10. Chen J, He J, Ogden LG, Batuman V, and Whelton PK. Relationship of serum antioxidant vitamins to serum creatinine in the US population. Am J Kidney Dis 39: 460-468, 2002.
11. Cuzzocrea S, McDonald MC, Mazzon E, Filipe HM, Centorrino T, Lepore V, Terranova ML, Ciccolo A, Caputi AP, and Thiemermann C. Beneficial effects of tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat. Crit Care Med 29: 102-111, 2001.
12. Fukai T, Folz RJ, Landmesser U, and Harrison DG. Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res 55: 239-249, 2002.
13. Griendling KK and FitzGerald GA. Oxidative stress and cardiovascular injury. Part II: animal and human studies. Circulation 108: 2034-2040, 2003.
14. Griendling KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000.
15. Guzik TJ, West NE, Pillai R, Taggart DP, and Channon KM. Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels. Hypertension 39: 1088-1094, 2002.
16. Harrison D, Griendling KK, Landmesser U, Hornig B, and Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 91: 7A-11A, 2003.
17. Harrison DG and Ohara Y. Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis: implications for impaired vasomotion. Am J Cardiol 75: 75B-81B, 1995.
18. Kipp DE and Rivers JM. Comparison of isotope dilution and excretion methods for determining the half-life of ascorbic acid in the guinea pig. J Nutr 114: 1386-1395, 1984.
19. Krier JD, Ritman EL, Bajzer Z, Romero JC, Lerman A, and Lerman LO. Noninvasive measurement of concurrent single-kidney perfusion, glomerular filtration, and tubular function. Am J Physiol Renal Physiol 281: F630-F638, 2001.
20. 2α in normal and hypercholesterolemic pigs. Am J Physiol Regul Integr Comp Physiol 283: R303-R308, 2002.
21. Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, Harrison DG, Hornig B, and Drexler H. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 106: 3073-3078, 2002.
22. Lerman LO, Nath KA, Rodriguez-Porcel M, Krier JD, Schwartz RS, Napoli C, and Romero JC. Increased oxidative stress in experimental renovascular hypertension. Hypertension 37: 541-546, 2001.
23. Lerman LO, Schwartz RS, Grande JP, Sheedy PF, and Romero JC. Noninvasive evaluation of a novel swine model of renal artery stenosis. J Am Soc Nephrol 10: 1455-1465, 1999.
24. Liao JK, Shin WS, Lee WY, and Clark SL. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 270: 319-324, 1995.
25. Libby P and Aikawa M. Vitamin C, collagen, and cracks in the plaque. Circulation 105: 1396-1398, 2002.
26. Lincoln TM and Keely SL. Effects of acetylcholine and nitroprusside on cGMP-dependent protein kinase in the perfused rat heart. J Cyclic Nucleotide Res 6: 83-91, 1980.
27. Meydani M. Vitamin E and atherosclerosis: beyond prevention of LDL oxidation. J Nutr 131: 366S-368S, 2001.
28. Mitchell JB, Samuni A, Krishna MC, DeGraff WG, Ahn MS, Samuni U, and Russo A. Biologically active metal-independent superoxide dismutase mimics. Biochemistry 29: 2802-2807, 1990.
29. National Institutes of Health. US Renal Data System Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2002.
30. Ness AR, Chee D, and Elliott P. Vitamin C and blood pressure - an overview. J Hum Hypertens 11: 343-350, 1997.
31. Noiri E, Nakao A, Uchida K, Tsukahara H, Ohno M, Fujita T, Brodsky S, and Goligorsky MS. Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol 281: F948-F957, 2001.
32. Nowzari FB, Davidson SD, Eshghi M, Mallouh C, Tazaki H, and Konno S. Adverse effects of oxidative stress on renal cells and its prevention by antioxidants. Mol Urol 4: 15-19, 2000.
33. Ortiz MC, Manriquez MC, Romero JC, and Juncos LA. Antioxidants block angiotensin II-induced increases in blood pressure and endothelin. Hypertension 38: 655-659, 2001.
34. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, and Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996.
35. Reckelhoff JF and Romero JC. Role of oxidative stress in angiotensin-induced hypertension. Am J Physiol Regul Integr Comp Physiol 284: R893-R912, 2003.
36. Ren Y, Carretero OA, and Garvin JL. Mechanism by which superoxide potentiates tubuloglomerular feedback. Hypertension 39: 624-628, 2002.
37. Rodriguez J, Grau A, Eguinoa E, Nespereira B, Perez-Ilzarbe M, Arias R, Belzunce M, Paramo J, and Martinez-Caro D. Dietary supplementation with vitamins C and E prevents downregulation of endothelial NOS expression in hypercholesterolemia in vivo and in vitro. Atherosclerosis 165: 33, 2002.
38. Rodriguez-Porcel M, Lerman A, Best PJ, Krier JD, Napoli C, and Lerman LO. Hypercholesterolemia impairs myocardial perfusion and permeability: role of oxidative stress and endogenous scavenging activity. J Am Coll Cardiol 37: 608-615, 2001.
39. Rodriguez-Porcel M, Lerman LO, Holmes DR Jr, Richardson D, Napoli C, and Lerman A. Chronic antioxidant supplementation attenuates nuclear factor-κB activation and preserves endothelial function in hypercholesterolemic pigs. Cardiovasc Res 53: 1010-1018, 2002.
40. Safian RD and Textor SC. Renal-artery stenosis. N Engl J Med 344: 431-442, 2001.
41. Salom MG, Lahera V, and Romero JC. Role of prostaglandins and endothelium-derived relaxing factor on the renal response to acetylcholine. Am J Physiol Renal Fluid Electrolyte Physiol 260: F145-F149, 1991.
42. Schnackenberg CG. Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am J Physiol Regul Integr Comp Physiol 282: R335-R342, 2002.
43. Schnackenberg CG, Welch WJ, and Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 32: 59-64, 1998.
44. Schnackenberg CG and Wilcox CS. The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. Kidney Int 59: 1859-1864, 2001.
45. Shokoji T, Nishiyama A, Fujisawa Y, Hitomi H, Kiyomoto H, Takahashi N, Kimura S, Kohno M, and Abe Y. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension 41: 266-273, 2003.
46. Stulak JM, Lerman A, Porcel MR, Caccitolo JA, Romero JC, Schaff HV, Napoli C, and Lerman LO. Renal vascular function in hypercholesterolemia is preserved by chronic antioxidant supplementation. J Am Soc Nephrol 12: 1882-1891, 2001.
47. Textor SC and Wilcox CS. Renal artery stenosis: a common, treatable cause of renal failure? Annu Rev Med 52: 421-442, 2001.
48. Ueda A, Nagase S, Yokoyama H, Tada M, Noda H, Ohya H, Kamada H, Hirayama A, and Koyama A. Importance of renal mitochondria in the reduction of TEMPOL, a nitroxide radical. Mol Cell Biochem 244: 119-124, 2003.
49. Ueda J, Saito N, Shimazu Y, and Ozawa T. A comparison of scavenging abilities of antioxidants against hydroxyl radicals. Arch Biochem Biophys 333: 377-384, 1996.
50. Ulker S, McKeown PP, and Bayraktutan U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 41: 534-539, 2003.
51. Wang D, Chen Y, Chabrashvili T, Aslam S, Borrego Conde LJ, Umans JG, and Wilcox CS. Role of oxidative stress in endothelial dysfunction and enhanced responses to angiotensin II of afferent arterioles from rabbits infused with angiotensin II. J Am Soc Nephrol 14: 2783-2789, 2003.
52. Wardle EN. Antioxidants in the prevention of renal disease. Ren Fail 21: 581-591, 1999.
53. 1 receptors in renal hemodynamics and oxygenation in the postclipped 2K,1C kidney. Hypertension 41: 692-696, 2003.
54. Wilcox CS and Welch WJ. Interaction between nitric oxide and oxygen radicals in regulation of tubuloglomerular feedback. Acta Physiol Scand 168: 119-124, 2000.
55. Wilson SH, Chade AR, Feldstein A, Sawamura T, Napoli C, Lerman A, and Lerman LO. Lipid-lowering independent effects of simvastatin on the kidney in experimental hypercholesterolemia. Nephrol Dial Transplant 18: 703-709, 2003.